OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome
Venkatesh Pooladanda, Sowjanya Thatikonda, Sai Priya Muvvala, et al.
International Journal of Pharmaceutics (2021) Vol. 601, pp. 120536-120536
Open Access | Times Cited: 20

Showing 20 citing articles:

Polysaccharide-Based Nanomedicines Targeting Lung Cancer
Asif Ahmad Bhat, Gaurav Gupta, Khalid Saad Alharbi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2788-2788
Open Access | Times Cited: 62

Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells
Arianna Rinaldi, Florence Dumas, Jason Thomas Duskey, et al.
International Journal of Pharmaceutics (2024) Vol. 654, pp. 123994-123994
Closed Access | Times Cited: 6

Directing mineralization of ZnO nanoparticles in cyanobacterial liquid crystalline polysaccharides for cancer therapies
Pruetsakorn Saosamniang, Kazuaki Matsumura, Maiko K. Okajima, et al.
International Journal of Biological Macromolecules (2025), pp. 140716-140716
Closed Access

Global research landscape on nanotechnology in acute lung injury: a bibliometric analysis
Jian Zhang, Shasha Jiang, Jipeng Jiang, et al.
Frontiers in Digital Health (2025) Vol. 7
Open Access

Glycyrrhetinic acid: A potential drug for the treatment of COVID-19 cytokine storm
Huawei Li, Jia You, Xi Yang, et al.
Phytomedicine (2022) Vol. 102, pp. 154153-154153
Open Access | Times Cited: 16

Advances in therapeutic nanodrug delivery systems for infectious lung diseases: a review
Gang Sheng, Na Tian, Huijuan Duan, et al.
Acta Materia Medica (2022) Vol. 1, Iss. 3
Open Access | Times Cited: 12

BRD4 as a Therapeutic Target in Pulmonary Diseases
Xia Guo, Ayobami Matthew Olajuyin, Torry A. Tucker, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13231-13231
Open Access | Times Cited: 5

Relevance of BET Family Proteins in SARS-CoV-2 Infection
Nieves Lara-Ureña, Mario García‐Domínguez
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1126-1126
Open Access | Times Cited: 13

Network pharmacology and experimental validation identify the potential mechanism of sophocarpine for COVID-19
Huixian Zhang, Xin Zhang
Journal of Medical Microbiology (2022) Vol. 71, Iss. 5
Closed Access | Times Cited: 4

Bromodomain protein 4 mediates the roles of TGFβ1-induced Stat3 signaling in mouse liver fibrogenesis
Feifan Xu, Sidan Lu, Xin Jia, et al.
Toxicology Letters (2023) Vol. 385, pp. 42-50
Closed Access | Times Cited: 2

Medicinal Herbal Extracts: Therapeutic Potential in Acute Lung Injury
Jae‐Won Lee, Hee Jae Lee, Seok Han Yun, et al.
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 700-715
Open Access

Niosomal gel improves dermal delivery of nimbolide: a promising approach for treatment of psoriasis
Sowjanya Thatikonda, Sai Prabha Rasoju, Venkatesh Pooladanda, et al.
Nanomedicine (2024), pp. 1-16
Closed Access

Nanotherapy therapy for acute respiratory distress syndrome: a review
Yanni Yu, Liping Qiu
Frontiers in Medicine (2024) Vol. 11
Open Access

Protective effect of olopatadine hydrochloride against LPS-induced acute lung injury: via targeting NF-κB signaling pathway
Jaspreet Kaur, Priyanka Rana, Tushar Matta, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 603-627
Closed Access

Page 1

Scroll to top